Deals Abound At Advanz

Company Has Closed Or Signed Several Agreements Since Early September

 
• By Chloe Kent

Advanz has acquired exclusive rights to register and commercialize a Phase III candidate from Dimerix in multiple territories, alongside agreements with Kyowa Kirin, Bayer and GP Pharm.

Mixed media image showing two men shaking hands superimposed over a cityscape
Advanz has signed or completed four major deals over the last few weeks • Source: Shutterstock

More from Deals

More from Business